STAND Therapeutics
Before making an inquiry
Download PDF
STAND Therapeutics Company Profile
We will contribute to the creation of innovative pharmaceuticals for difficult-to-treat diseases!
Our company was established in November 2019 and is engaged in the development of innovative drugs utilizing stable intracellular antibodies (STAND). Unlike conventional antibodies that are unstable and aggregate within cells, STAND technology provides a versatile antibody that remains stable in the intracellular environment and can approach disease treatment targets. Through fundraising and technology development, we aim to realize innovative therapies for various diseases.
Business Activities
■Drug discovery business using intracellular antibody STAND technology, joint drug development business, support business for veterinary drug development, support business for research reagent development.
Products/Services (1)
catalog（1）
Survey responses are required to view e-book details. Click to view the e-book.
Detailed information
| Company name | STAND Therapeutics |
|---|---|
| Contact address | postalcode 103-0023 Tokyo/ Chuo-ku/ 2-3-11 Nihonbashi Honcho, Nihonbashi Life Science Building B1FView on map TEL：03-6868-4720 |
| Industry | others |